Story Poster

What Are The Georgia Bulldogs Getting In 4-Star CB Justyn Rhett?

April 18, 2022

DON’T MISS OUT: Get our insider newsletter today!

ATHENS - Kirby Smart and the Georgia Bulldogs land another impressive cornerback commitment in the 2023 class.

They already have in-state speedster Marcus Washington‍ on board, and today they’ve landed a commitment from four-star Justyn Rhett‍.

The former Notre Dame commitment took his official visit to Georgia the weekend of G-Day, and that was the end of his commitment to the Fighting Irish. Dawg Post was told the Bulldogs should be seen as the team to beat moving forward, and today they landed his verbal commitment.

So what will Rhett bring to Athens?

Length and physicality. 

At 6-foot-1 195-pounds, Rhett is a tough, physical corner who knows how to tackle. He’s along and athletic, so there aren’t many quarterbacks who test his side of the field. When they do, Rhett doees a good job of knocking the ball away. His long arms allow him to be physical on the line, but his knack for breaking up passes is why he’s one of the nation’s best.

The state of Georgia is loaded with impact defensive backs, but Fran Brown and the Georgia staff went across the country to land their guy.

The Las Vegas native checks just about every box you look for in an impact cornerback. Smart praised the toughness of freshman cornerback Daylen Everette and his willingness to tackle after G-Day, and Rhett will bring that type of presence to Athens.

If you can’t tackle and play physical, you aren’t going to play a ton at cornerback for the Georgia Bulldogs. Add in Rhett’s length, speed, footwork, and natural cover skills and you’ve got a cornerback with a really high ceiling.

The Bishop Gorman (NV) standout is ranked as the No. 12 CB prospect in the country according to the 247 Composite Rankings.

Check out Dawgstruction - our coffee table book about the 2021 national title... CLICK HERE TO ORDER NOW

subscribe Verify your student status
See Subscription Benefits
Trial only available to users who have never subscribed or participated in a previous trial.